Bristol-myers Squibb Company (BMY) fundamentals from SEC filings — revenue $48.2B, net margin 14.6%, diluted EPS $3.46 in FY2025. Revenue, margins, EPS and free cash flow, year by year.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $46.4B | $46.2B | $45.0B | $48.3B | $48.2B |
| Net income | $7.0B | $6.3B | $8.0B | -$8.9B | $7.1B |
| Net margin | 15.1% | 13.7% | 17.8% | -18.5% | 14.6% |
| Diluted EPS | $3.12 | $2.95 | $3.86 | $-4.41 | $3.46 |
| Free cash flow | $15.2B | $11.9B | $12.7B | $13.9B | $12.8B |
Figures are as reported to the SEC (EDGAR companyfacts), in the filer's own fiscal years.
Sign in to PortfolioX for the full analysis — ten years of history, segment and geographic breakdowns, valuation multiples, analyst estimates and filings. · PortfolioX home